01 9Follistim AQ
02 2Follistim Aq
Main Therapeutic Indication : Urology
Currency : USD
2020 Revenue in Millions : 193
2019 Revenue in Millions : 241
Growth (%) : -20
Main Therapeutic Indication : Urology
Currency : USD
2021 Revenue in Millions : 237
2020 Revenue in Millions : 193
Growth (%) : 23
Main Therapeutic Indication : Women's Health
Currency : USD
2022 Revenue in Millions : 229
2021 Revenue in Millions : 237
Growth (%) : -3
Main Therapeutic Indication : Women's Health
Currency : USD
2023 Revenue in Millions : 262
2022 Revenue in Millions : 229
Growth (%) : 14
Main Therapeutic Indication : Women?s Health
Currency : USD
2024 Revenue in Millions : 237
2023 Revenue in Millions : 262
Growth (%) : -10
Main Therapeutic Indication : Sexual Health
Currency : USD
2015 Revenue in Millions : 412
2014 Revenue in Millions : 383
Growth (%) : -7%
Main Therapeutic Indication : Sexual Health
Currency : USD
2014 Revenue in Millions : -14.30%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Sexual Health
Currency : USD
2016 Revenue in Millions : 355
2015 Revenue in Millions : 383
Growth (%) : -7
Main Therapeutic Indication : Sexual Health
Currency : USD
2017 Revenue in Millions : 298
2016 Revenue in Millions : 355
Growth (%) : -16
Main Therapeutic Indication : Sexual Health
Currency : USD
2018 Revenue in Millions : 268
2017 Revenue in Millions : 298
Growth (%) : -10%
